Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia

References

• Benigni A, Orisio S, Gaspari F, Frusca T, Amuso G, Remuzzi G. 1992. Evidence against a pathogenic role for endothelin in pre-eclampsia. British Journal of Obstetrics and Gynaecology 99:798–802.
   PubMedGoogle Scholar
• Bhattacharjee G, Asplin IR, Wu SM, Gawdi G, Pizzo SV. 2000. The conformation-dependent interaction of 2-macroglobulin with vascular endothelial growth factor. Journal of Biological Chemistry 275:26806–26811.
   PubMed Web of Science ®Google Scholar
• Bosio PM, Wheeler T, Anthony F, Conroy R, O'herlihy C, McKenna P. 2001. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. American Journal of Obstetrics and Gynecology 184:146–152.
   PubMed Web of Science ®Google Scholar
• Bussen S, Bussen D. 2011. Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome. Archives of Gynecology and Obstetrics 284:551–557.
   PubMed Web of Science ®Google Scholar
• Celik H, Avci B, Alper T. 2012. Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies. Pregnancy Hypertension 2:39–42.
   PubMedGoogle Scholar
• Fernandez-Patron C, Radomski MW, Davidge ST. 1999. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circulation Research 85:906–911.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Houck K, Jakeman I, Leung DW. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Reviews 13:18.
   PubMed Web of Science ®Google Scholar
• George E, Palei AC, Granger JP. 2012. Endothelin as a final pathway in the pathophysiology of preeclampsia: therapeutic implications. Current Opinion in Nephrology and Hypertension 21:157–162.
   PubMed Web of Science ®Google Scholar
• Hefler L, Obermair A, Husslein P, Kainz C, Tempfer C. 2000. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 79:77–78.
   PubMedGoogle Scholar
• Hunter A, Aitkenhead M, Caldwell C, McCraken G, Wilson D, McClure N. 2000. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36:965–969.
   PubMed Web of Science ®Google Scholar
• Ingh EA, Ahman B, Armir RE, Wang I. 2001. Endothelin-1 in fetoplacental tissues from normotensive pregnant women and women with preeclampsia. Acta Obstetricia et Gynecologica 80:99–103.
   PubMedGoogle Scholar
• Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boji R, et al. 2009. Novel approaches for mechanistics understanding and predicting pre-eclampsia. Journal of Reproductive Immunology 83:134–138.
   PubMedGoogle Scholar
• Khedun S, Naicker T, Moodley J. 2002. Endothelin-1 activity in pregnancy. Journal of Obstetrics and Gynaecology 22:590–593.
   Google Scholar
• LaMarca BD, Alexander BT, Gilbert JS, Ryan MJ. 2008. Pathophysiology of Hypertension in response to placental ischemia during pregnancy: A central role for Endothelin?Gender Medicine 5:133–S138.
   Google Scholar
• Lee ES, Oh MJ, Jung JW, Lim JE, Seol HJ, Lee KJ, et al. 2007. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. Journal of Korean Medical Science 22:94–98.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine 350:672–683.
   PubMed Web of Science ®Google Scholar
• Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. 2000. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. American Journal of Obstetrics and Gynecology 183:1554–1557.
   PubMed Web of Science ®Google Scholar
• Lumme R, Laatikainen T, Vuolteenaho O, Leppaluoto J. 1992. Plasma endothelin, atrial natriuretic peptide (ANP) and uterine and umbilical artery flow velocity waveforms in hypertensive pregnancies. British Journal of Obstetrics and Gynaecology 99:761–764.
   PubMedGoogle Scholar
• Lyall F, Greer IA, Boswell F, Fleming R. 1997. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and preeclampsia. British Journal of Obstetrics and Gynaecology 104: 223–228.
   PubMedGoogle Scholar
• Mastrogiannis DS, O’Brien WF, Krammer J, Benoit R. 1991. Potential role of endothelin-1 in normal and hypertensive pregnancies. Journal of Obstetrics and Gynaecology 165:1711–1716.
   Google Scholar
• Murphy SR, Lamarca BB, Cockrell K, Granger JP. 2010. Role of endothelin in mediating soluble fms-like tyrosine kinase 1 induced hypertension in pregnant rats. Hypertension 55:394–398.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Thibault G. 1991. Plasma endothelin in human essential hypertension. American Journal of Hypertension 4(4 Pt 1):303–308.
   PubMedGoogle Scholar
• Schiffrin EL. 1995. Endothelin -Potential role in hypertension and vascular hypertrophy. Hypertension 25:1135–1142.
   PubMed Web of Science ®Google Scholar
• Sharma D, Singh A, Trivedi SS, Bhattacharjee J. 2011. Role of endothelin and inflammatory cytokines in pre-eclampsia: A pilot North Indian study. American Journal of Reproductive Immunology 65:428–432.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupfermine M. 2005. Preeclampsia. Lancet 365:785–799.
   PubMed Web of Science ®Google Scholar
• Taylor CM, Stevens H, Anthony FW, Wheeler T. 1997. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, JAr and BeWo. Placenta 18:451–458.
   PubMed Web of Science ®Google Scholar
• Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioğlu M. 2010. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha. Journal of Maternal-Fetal and Neonatal Medicine 23:880–886.
   PubMed Web of Science ®Google Scholar
• Tsurumi Y, Murohara T, Krasinsk K, Chen D, Witzenbichler B, Kearney M, et al. 1997. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Medicine 3:879–886.
   PubMed Web of Science ®Google Scholar
• Yücesoy G, Ozkan S, Bodur H, Tan T, Calişkan E, Vural B, et al. 2005. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorders of pregnancy: a seven years experience of a tertiary center. Archives of Gynecology and Obstetrics 273:43–49.
   PubMedGoogle Scholar